Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00277-021-04404-3.pdf
Reference31 articles.
1. Krishnan A, Vij R, Keller J, Dhakal B, Hari P (2016) Moving beyond autologous transplantation in multiple myeloma: consolidation, maintenance, allogeneic transplant, and immune therapy. Am Soc Clin Oncol Educ Book 35:210–221
2. Nooka AK, Lonial S (2016) New targets and new agents in high-risk multiple myeloma. Am Soc Clin Oncol Educ Book 35:e431–e441
3. Montefusco V, Corso A, Galli M, Ardoino I, Pezzatti S, Carniti C, Patriarca F, Gherlinzoni F, Zambello R, Sammassimo S, Marcatti M, Nozza A, Crippa C, Cafro AM, Baldini L, Corradini P (2020) Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse. Br J Haematol 188:907–917
4. Bewick V, Cheek L, Ball J (2004) Statistics review 11: assessing risk. Crit Care 8:287–291
5. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic strategies to enhance immune response induced by multiple myeloma cells;Frontiers in Immunology;2023-05-18
2. Relapsed and refractory multiple myeloma: A systematic review and network meta‐analysis of the efficacy of novel therapies;British Journal of Haematology;2023-01-20
3. Fine‐needle aspiration cytology for the diagnosis of plasma cell neoplasms in the head and neck region: A systematic analysis of the literature;Diagnostic Cytopathology;2022-12-28
4. How to Manage Patients with Lenalidomide-Refractory Multiple Myeloma;Cancers;2022-12-27
5. Interaction of Bortezomib with Cell Membranes Regulates Its Toxicity and Resistance to Therapy;Membranes;2022-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3